拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
乙型肝炎肝硬化患者肝组织中有较高的HBV复制率；
The results suggest that HBV replication rate were higher in the liver tissues of these patients.
结论乙型肝炎肝硬化患者肝移植后预防乙型肝炎复发应采用HBVDNA、YMDD变异及血清标志物联合检测。
Conclusion the combination detection of YMDD variants, HBV DNA and HBV serum markers may define HBV reinfection after liver transplantation in the patients with hepatitis b.
平均年龄在56岁，酒精性肝硬化患者占47%，乙型肝炎和丙型肝炎患者共占39%。
The median age was 56, 47% had alcoholic cirrhosis and 39% had hepatitis B or C.
肝硬化的病因以乙型肝炎为主。
The major etiology of cirrhosis was chronic viral hepatitis.
结论血清il - 6和IL - 8水平是反映乙型肝炎后肝硬化肝功能损害程度及判断病情预后的重要指标。
Conclusion IL-6 and IL-8 were important target to reflect hepatic function damage of type B posthepatitic cirrhosis and to judge prognosis of posthepatic cirrhosis.
现己证实，乙型肝炎病毒除引起肝炎、肝硬化及肝癌外，还能引起肝外多器官病变。
That HBV can lead to other organs'lesions, such as different kind of glomerulonephropathy , except hepatitis, liver cirrhosis and hepatocellular carcinoma has been confirmed.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
乙型肝炎病毒(HBV)是人类急慢性肝炎、肝硬化和肝细胞癌的主要病因。
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans.
乙型肝炎病毒(HBV)是人类急慢性肝炎、肝硬化和肝细胞癌的主要病因。
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans.
应用推荐